Skip to main content

Want a detailed portfolio tracker?

Absci (ABSI) P/E (2021 - 2026)

Absci (ABSI) P/E from Jul 22, 2021 to Jul 20, 2026. The TTM Absci (ABSI) P/E is -9.66. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Absci (ABSI)

YearP/EChange
2026-9.66+146.67%
2025-3.92+35.37%
2024-2.89-20.78%
2023-3.65+107.32%
2022-1.76-72.23%
2021-6.34N/A

Comparison Absci (ABSI) P/E with competitors

Absci (ABSI) P/E is -9.66.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.77%
FGENFibroGen Inc0.24-102.48%
CHRSCoherus Biosciences Inc0.85-108.78%
FBIOFortress Biotech Inc0.95-109.82%
ORMPOramed Pharmaceuticals Inc1.50-115.56%
AGENAgenus Inc3.01-131.15%
INVAInnoviva Inc3.15-132.64%
VXRTVaxart Inc3.55-136.74%
CRMDCorMedix Inc3.63-137.55%
CVACCureVac N.V.4.45-146.01%
GLPGGalapagos NV4.86-150.28%
SRPTSarepta Therapeutics Inc4.88-150.52%
ABEOAbeona Therapeutics Inc5.39-155.76%
ZVRAZevra Therapeutics Inc5.89-160.93%
SPROSpero Therapeutics Inc6.23-164.46%
CGENCompugen Ltd6.31-165.34%
RIGLRigel Pharmaceuticals6.87-171.12%
SLXNSilexion Therapeutics Corp7.30-175.51%
OMEROmeros Corporation9.26-195.82%
AUPHAurinia Pharmaceuticals Inc9.58-199.19%
PLXProtalix BioTherapeutics Inc10.89-212.71%
ACADAcadia Pharmaceuticals Inc11.73-221.38%
TBPHTheravance Biopharma Inc12.26-226.90%
ADMAAdma Biologics Inc12.42-228.52%
HRMYHarmony Biosciences Holdings Inc13.82-243.03%
SABSSAB Biotherapeutics Inc14.14-246.30%
NAGENiagen Bioscience Inc14.82-253.35%
INCYIncyte Corp15.82-263.75%
REGNRegeneron Pharmaceuticals Inc15.86-264.10%
PBYIPuma Biotechnology Inc17.32-279.20%
CPRXCatalyst Pharmaceuticals Inc17.44-280.48%
EXELExelixis Inc17.54-281.50%
TGTXTG Therapeutics Inc18.97-296.28%
MDXGMimedx Group Inc20.55-312.70%
XOMAXOMA Royalty Corp22.87-336.74%
ARGXArgen X SE24.30-351.47%
CTMXCytomX Therapeutics Inc24.82-356.88%
XOMAOXOMA Royalty Corp25.34-362.30%
HALOHalozyme Therapeutics Inc25.62-365.19%
XOMAPXOMA Royalty Corp25.67-365.67%
VRTXVertex Pharmaceuticals Inc27.99-389.73%
RPRXRoyalty Pharma plc - Class A28.69-396.90%
SLNOSoleno Therapeutics Inc29.02-400.29%
ASNDAscendis Pharma A/S30.09-411.36%
LGNDLigand Pharmaceuticals Inc - Class B37.91-492.36%
APLSApellis Pharmaceuticals Inc39.02-503.84%
BMRNBiomarin Pharmaceutical Inc42.21-536.86%
KRYSKrystal Biotech Inc45.34-569.27%
ONCBeiGene Ltd69.54-819.69%
PHARPharming Group N.V.75.03-876.46%
TECHBio-Techne Corp101.96-1155.20%
VCELVericel Corp109.92-1237.61%
ALNYAlnylam Pharmaceuticals Inc117.96-1320.86%
GMABGenmab140.29-1551.91%
TLXTelix Pharmaceuticals Ltd162.15-1778.17%
CORTCorcept Therapeutics Inc212.86-2302.93%